Provider intervention associated with usage decline of high risk meds

Intervention impacts use of high-risk drugs in CMS Star metric

September 21, 2017

Intervention designed to impact use of high-risk medications evaluated as part of CMS Star metric

Prime sent letters to doctors to let them know they had prescribed high-risk medications to Medicare members. The intervention group’s high-risk medication percentage declined more than the control group. It was a statistically significant difference. Certain medications carry a greater risk of adverse events for the older adults than for younger people. Safer options exist for many high-risk medications.

Impact of First Fill Intervention on High-risk Medication Usage in a One Million Member Medicare Population (Fall 2016)

Related news

Perspectives

August 4, 2022

Specialty Pipeline Update: July 2022

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

August 4, 2022

Traditional Drug Pipeline Update: July 2022

This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…

Perspectives

July 26, 2022

Working together to lead the way

We often have the impression that advancing and leading in your career requires…